首页> 美国卫生研究院文献>Neoplasia (New York N.Y.) >Telomerase Activity Detected by Quantitative Assay in Bladder Carcinoma and Exfoliated Cells in Urine
【2h】

Telomerase Activity Detected by Quantitative Assay in Bladder Carcinoma and Exfoliated Cells in Urine

机译:定量分析检测膀胱癌和尿液脱落细胞中的端粒酶活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Early diagnosis is one of the most determining factors for patient survival. The detection of telomerase activity is a potentially promising tool in the diagnosis of bladder and other types of cancer due to the high expression of this enzyme in tumor cells. We carried out a quantitative evaluation of telomerase activity in urine samples in an attempt to determine a cut-off capable of identifying cancer patients. Telomerase activity was quantified by fluorescence TRAP assay in urine from 50 healthy volunteers and in urine and bioptic tumor samples from 56 previously untreated bladder cancer patients and expressed in arbitrary enzymatic units (AEU). Telomerase activity in urine ranged from 0 to 106 AEU (median 0) in healthy donors and from 0 to 282 AEU (median 87) in patients with cancer. A telomerase expression higher than the cut off value determined by receiver operating characteristic (ROC) analysis was observed in 78% of cases, regardless of tumor grade and in 71% (15/21) of cases of nonassessable or negative cytology. The quantitative analysis of telomerase activity in urine enabled us to define cut-off values characterized by different sensitivity and specificity. Cytologic and telomerase determination, used sequentially, enabled us to detect about 90% of tumors.
机译:早期诊断是患者生存的最决定性因素之一。由于该酶在肿瘤细胞中的高表达,端粒酶活性的检测是诊断膀胱癌和其他类型癌症的潜在有前途的工具。我们对尿液样本中的端粒酶活性进行了定量评估,以试图确定能够识别癌症患者的临界值。通过荧光TRAP测定法对来自50名健康志愿者的尿液以及来自56名先前未接受治疗的膀胱癌患者的尿液和活检肿瘤样品中的端粒酶活性进行了定量,并以任意酶单位(AEU)表示。在健康供体中,尿中端粒酶活性的范围为0至106 AEU(中位数0),对于癌症患者,其端粒酶活性为0至282 AEU(中位数87)。在78%的病例中观察到端粒酶表达高于通过接受者操作特征(ROC)分析确定的临界值,而与肿瘤等级无关,在71%(15/21)的病例中无法评估或阴性细胞学检查。尿液中端粒酶活性的定量分析使我们能够定义以不同的敏感性和特异性为特征的临界值。顺序使用细胞学和端粒酶测定,使我们能够检测到约90%的肿瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号